Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, the financial performance is weak with significant declines in net income and EPS, and there are no positive catalysts or trading signals to support a buy decision. The lack of news, trading trends, and analyst ratings further diminishes the appeal of this stock.

Technical Analysis

The stock is in a bearish trend with MACD below 0 and negatively contracting, RSI in the neutral zone at 37.082, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The pre-market price is $1.09, down -3.67%, with key support at $1.017 and resistance at $1.162.

Positive Catalysts

NULL identified. No news, trading trends, or positive financial growth.

Neutral/Negative Catalysts

Weak financial performance with a -37.97% YoY drop in net income and a -97.35% YoY drop in EPS. The stock is also in a bearish technical trend, and there are no trading signals or recent news to support a positive outlook.

Financial Performance

In Q3 2025, the company reported no revenue growth (0% YoY), a net income drop of -37.97% YoY to -$2,347,302, and a significant EPS decline of -97.35% YoY to -1.05. Gross margin remained at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast SHPH stock price to rise

Buy

Hold

Sell

Current: 0.890

Low

Averages

High